US20010014753A1 - Catalyst composition and method for producing diaryl carbonates, using bisphosphines - Google Patents

Catalyst composition and method for producing diaryl carbonates, using bisphosphines Download PDF

Info

Publication number
US20010014753A1
US20010014753A1 US09/813,394 US81339401A US2001014753A1 US 20010014753 A1 US20010014753 A1 US 20010014753A1 US 81339401 A US81339401 A US 81339401A US 2001014753 A1 US2001014753 A1 US 2001014753A1
Authority
US
United States
Prior art keywords
component
composition
bromide
lead
palladium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US09/813,394
Other versions
US6407027B2 (en
Inventor
Grigorii Soloveichik
Ben Patel
John Ofori
Kirill Shalyaev
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US09/813,394 priority Critical patent/US6407027B2/en
Publication of US20010014753A1 publication Critical patent/US20010014753A1/en
Application granted granted Critical
Publication of US6407027B2 publication Critical patent/US6407027B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C68/00Preparation of esters of carbonic or haloformic acids
    • C07C68/01Preparation of esters of carbonic or haloformic acids from carbon monoxide and oxygen

Definitions

  • This invention relates to the preparation of diaryl carbonates by carbonylation. More particularly, it relates to the improvement of diaryl carbonate yield in the carbonylation reaction.
  • Diaryl carbonates are valuable intermediates for the preparation of polycarbonates by transesterification with bisphenols in the melt.
  • This method of polycarbonate preparation has environmental advantages over methods that employ phosgene, a toxic gas, as a reagent and environmentally detrimental chlorinated aliphatic hydrocarbons such as methylene chloride as solvents.
  • metal-based cocatalysts have been described broadly in U.S. Pat. Nos. 4,187,242, 4,201,721 and 5,380,907. Lead compounds as cocatalysts are particularly detailed in U.S. Pat. No. 5,498,789. Also preferred in general is the use of various halides, as illustrated by tetra-n-butylammonium bromide. Compounds characterized as inert solvents, such as toluene, diethyl ether, diphenyl ether and acetonitrile, can also be present.
  • the present invention is based on the discovery that the presence of bisphosphines in carbonylation catalyst systems, whether added separately or as a preformed complex with the Group VIII metal, affords a catalyst with good activity and relatively long storage stability.
  • the invention is directed to a method for preparing a diaryl carbonate.
  • An embodiment of the method comprises contacting at least one hydroxyaromatic compound with oxygen and carbon monoxide in the presence of a catalytic amount of a catalyst composition comprising at least one organic bisphosphine and the following optional components and any reaction products thereof: a Group VIII metal having an atomic number of at least 44 or a compound thereof; at least one bromide or chloride salt; and at least one cocatalyst which is a compound of a metal other than a Group VIII metal having an atomic number of at least 44.
  • Another aspect of the invention is catalyst compositions comprising the aforementioned components and any reaction products thereof.
  • Any hydroxyaromatic compound may be employed in the method of the present invention.
  • Monohydroxyaromatic compounds such as phenol, the cresols, the xylenols and p-cumylphenol, are generally preferred with phenol being most preferred.
  • the invention may, however, also be employed with dihydroxyaromatic compounds such as resorcinol, hydroquinone and 2,2-bis(4-hydroxyphenyl)propane or “bisphenol A”, whereupon the products are polycarbonate oligomers.
  • diaryl carbonate preparation method of the invention are oxygen and carbon monoxide, which react with the phenol to form the desired diaryl carbonate. They may be employed in high purity form or diluted with another gas such as nitrogen, argon or carbon dioxide, which has no negative effect on the reaction.
  • the constituents of the catalyst system of the invention are defined as “components” irrespective of whether a reaction between said constituents occurs before or during the carbonylation reaction.
  • the catalyst system may include said components and any reaction products thereof.
  • Component A of the catalyst system is one of the heavy Group VIII metals, preferably palladium, or a compound thereof.
  • useful palladium materials include elemental palladium-containing entities such as palladium black, palladium/carbon, palladium/alumina and palladium/silica; palladium compounds such as palladium chloride, palladium bromide, palladium iodide, palladium sulfate, palladium nitrate, palladium acetate and palladium 2,4-pentanedionate; and palladium-containing complexes involving such compounds as carbon monoxide, amines, nitrites, phosphines and olefins.
  • palladium(II) salts of organic acids most often C 2-6 aliphatic carboxylic acids
  • palladium(II) salts of ⁇ -diketones Palladium(II) acetate and palladium(II) 2,4-pentanedionate are generally most preferred. Mixtures of the aforementioned palladium materials are also contemplated.
  • Component B is at least one bromide or chloride salt. It may be an alkali metal or alkaline earth metal halide, preferably a bromide such as lithium bromide, sodium bromide, potassium bromide, calcium bromide or magnesium bromide. It may also be a quaternary ammonium or quaternary phosphonium salt such as tetramethylammonium bromide, tetraethylammonium bromide, tetra-n-butylammonium bromide or tetramethylphosphonium bromide, or a hexaalkylguanidinium salt such as hexaethylguanidinium bromide.
  • a bromide such as lithium bromide, sodium bromide, potassium bromide, calcium bromide or magnesium bromide. It may also be a quaternary ammonium or quaternary phosphonium salt such as tetramethylammonium bromide, t
  • Component C is at least one organic bisphosphine.
  • organic is meant a compound containing at least one organic radical, with the proviso that said compound may also contain non-organic atoms or radicals.
  • the bisphosphine may often be characterized by the formula
  • each R 1 is independently a monovalent organic radical and R 2 is a divalent organic radical.
  • R 1 is an aromatic or alicyclic radical, preferably aromatic and most preferably phenyl.
  • the identity of the divalent R 2 radical is subject to wide variation. It may be aliphatic, as exemplified by ethylene, trimethylene, tetramethylene and neopentylene. It may also be aromatic, as illustrated by phenylene and naphthylene. Suitable radicals include those containing inorganic elements, as illustrated by aminobis(alkylene) and ferrocenylene. For the most part, aliphatic radicals are preferred and C 3-8 aliphatic radicals especially preferred.
  • Bisphosphines are included in the carbonylation catalyst system in catalytic amounts.
  • a “catalytic amount” is an amount of bisphosphine (or combination of bisphosphines) that increases the number of moles of diaryl carbonate produced per mole of Group VIII metal utilized; increases the number of moles of diaryl carbonate produced per mole of halide utilized; or increases selectivity toward diaryl carbonate production beyond that obtained in the absence of the bisphosphine (or combination of bisphosphines).
  • Optimum amounts of a bisphosphine in a given application will depend on various factors, such as the identity of reactants and reaction conditions.
  • component C the bisphosphine
  • the suspension thus formed was stirred for an additional 5 minutes at room temperature and then cooled in an ice bath for 30 minutes to complete precipitation.
  • the pale yellow precipitate was filtered in air on a medium pore fritted glass filter and washed with reagent grade hexane. It was then dried under vacuum.
  • the yield of the desired palladium(II) chloride bisphosphine complex whose structure was confirmed by phosphorus-31 nuclear magnetic resonance spectroscopy, was 1.062 g, or 94% of theoretical.
  • cocatalyst which is a compound of a metal other than a heavy Group VIII metal, preferably one which is soluble in the liquid phase under the reaction conditions.
  • a cocatalyst which is a compound of a metal other than a heavy Group VIII metal, preferably one which is soluble in the liquid phase under the reaction conditions.
  • Numerous other metal compounds are known in the art to be active as carbonylation cocatalysts, and any compound having such activity may be used according to the present invention provided an improvement in diphenyl carbonate production, usually yield, is achieved thereby.
  • Illustrative cocatalytic metals include cerium, titanium, copper, zinc, manganese, bismuth, europium and lead, which may be used singly or in combination. It should be noted, however, that not all possible permutations of component D are operative in all contexts; the effectiveness of any metal compound or combination of compounds for this purpose may be determined by simple experimentation.
  • the preferred cocatalytic compounds are those of lead.
  • lead compounds which may be employed are lead oxides such as PbO and Pb 3 O 4 ; inorganic lead salts such as lead(II) nitrate; lead carboxylates such as lead(II) acetate, lead(II)propionate and lead(IV) acetate; lead alkoxides and aryloxides such as lead(II) methoxide and lead(II) phenoxide; and lead salts of ⁇ -diketones such as lead(II) 2,4-pentanedionate. Mixtures of the aforementioned lead compounds may also be employed.
  • lead oxides such as PbO and Pb 3 O 4
  • inorganic lead salts such as lead(II) nitrate
  • lead carboxylates such as lead(II) acetate, lead(II)propionate and lead(IV) acetate
  • lead alkoxides and aryloxides such as lead(II) methoxide and lead(II) phenoxide
  • the preferred lead compounds are lead(II) oxide, lead(II) aryloxides and lead(II) 2,4-pentanedionate.
  • the preferred compounds of other metals are, for the most part, salts of P-diketones and especially 2,4-pentanedionates.
  • a subgenus of lead cocatalytic compounds that are particularly useful according to the invention is the subgenus of lead halophenoxides, typically having the formula
  • A is an aromatic radical
  • X is chlorine or bromine
  • n has a value in the range of 1-3
  • m has a value in the range of 0-1
  • z has a value in the range of 0.1-2.0.
  • A may be any aromatic radical, unsubstituted or substituted.
  • A corresponds to the diaryl carbonate to be formed in the carbonylation reaction. Therefore, it is usually unsubstituted phenyl.
  • X may be bromide or chloride and is preferably bromide.
  • n, m and z are as described hereinabove. Most often, n is 2.5-3 and m is 0.8-1.
  • the lead halophenoxides may be prepared by merely bringing into contact, usually at a temperature in the range of about 50-120° C., lead(II) oxide, at least one bromide or chloride salt and at least one hydroxyaromatic compound, most often phenol.
  • Suitable bromide and chloride salts include alkali metal and alkaline earth metal bromides and chlorides and tetraalkylammonium, tetraalkylphosphonium and hexaalkylguanidinium bromides and chlorides. The bromides are strongly preferred.
  • the bromide or chloride salt is an inorganic salt such as sodium bromide, the reaction is preferably facilitated by the presence of an electron-donating compound, especially a nitrile such as acetonitrile.
  • the molar ratio of lead to halide in the reaction mixture should be at least 2:1, since at lower molar ratios the principal products are the lead(II) halides and hydroxyhalides. In general, molar ratios in the range of about 2-20:1 are preferred. It should be noted, however, that the molar ratio of lead to halide in the product is not necessarily at least 2:1. Rather, the method of the invention involves this minimum since it permits isolation of the lead halophenoxide.
  • Hydroxyaromatic compound is most often present in excess and is preferably employed as a solvent for the reaction.
  • the electron-donating compound when employed, may also be present in molar excess with respect to halide salt, typically in a molar ratio in the range of about 50-200:1. Under such conditions, the lead halophenoxide forms a separate phase, which may be isolated by conventional methods including such operations as filtration and drying.
  • Suitable cosolvents include various polar organic liquids such as ethers including polyethylene glycol ethers, amides such as N-methylpyrrolidone, sulfones such as sulfolane and nitrites such as acetonitrile and adiponitrile. It should be noted, however, that component E is not effective to optimize diaryl carbonate formation for all possible permutations of component D; the combined effectiveness of the two for this purpose may be determined by simple experimentation.
  • a desiccant In addition to the aforementioned reactants and catalyst system, it is strongly preferred for a desiccant to be present in the reaction system.
  • the preferred desiccants are non-reactive materials such as molecular sieves, as illustrated by 3-Angstrom (hereinafter “3A”) molecular sieves. They are usually isolated from the other reactants, as by presence in a basket mounted to a stirrer shaft or the like.
  • Component A is most often present in the amount of about 0.1-10,000 ppm by weight of the appropriate Group VIII metal (usually palladium), based on hydroxyaromatic compound, and component B in the amount of about 1-2,000 equivalents of halide per equivalent of the Group VIII metal of component A.
  • Component C is present in an amount effective to form a complex with the metal of component A; this amount is generally at least a number of moles equal to the number of gram-atoms of metal in said component A, and preferably in a ratio of moles of component C to gram-atoms of said metal in the range of about 1.0-1.2:1.
  • Component D when present, is generally employed in the amount of about 0.2-200 gram-atoms of total metal per equivalent of the Group VIII metal of component A.
  • component E in the composition and method of the invention is believed to be to increase the degree of dissociation and ionization of the halide anion of component B, perhaps by forming a complex with the cationic portion of said component, although the invention is in no way dependent on this or any other theory of operation.
  • the amount of component E employed will be an amount effective to increase the yield of the desired diaryl carbonate as evidenced, for example, by an increase in “turnover number”; i.e., the number of moles of diaryl carbonate formed per gram-atom of palladium present. This amount is most often about 1-60% by volume based on the total of hydroxyaromatic compound and component E.
  • the method of the invention is preferably conducted in a reactor in which the hydroxyaromatic compound and catalyst system are charged under pressure of carbon monoxide and oxygen and heated.
  • the reaction pressure is most often within the range of about 1-500 and preferably about 1-150 atm.
  • Gas is usually supplied in proportions of about 1-50 mole percent oxygen with the balance being carbon monoxide and optionally one or more inert gases, and in any event outside the explosion range for safety reasons.
  • the gases may be introduced separately or as a mixture. Reaction temperatures in the range of about 60-150° C. are typical. It is often preferred to maintain a substantially constant gas pressure and partial pressure of carbon monoxide and oxygen, as described, for example, in U.S. Pat. No. 5,399,734, until conversion of the hydroxyaromatic compound is complete.
  • the diaryl carbonates produced by the method of the invention may be isolated by conventional techniques. It is often preferred to form and thermally crack an adduct of the diaryl carbonate with the hydroxyaromatic compound, as described in U.S. Pat. Nos. 5,239,106 and 5,312,955.
  • the reactor was sealed, flushed twice with carbon monoxide, pressurized with 88.4 atmospheres of a carbon monoxide-oxygen mixture containing 7.5% oxygen by volume and heated for 5 hours at 100° C., with vigorous stirring and periodic sampling via a sample dip tube.
  • each vial was capped with a snap cap having a slit with a polytetrafluoroethylene septum and the vials were placed in an autoclave which was pressurized to 88.4 atm with a mixture of 90 mole percent carbon monoxide and 10 mole percent oxygen and heated at 100° C. for 3 hours.
  • the contents of the vials were analyzed for diphenyl carbonate by vapor phase chromatography.
  • the results are given in Table III, in comparison with controls employing palladium(II) 2,4-pentanedionate as a catalyst.
  • TABLE III Heated Turnover Catalyst mixture Turnover number, Example storage, hrs. storage, hrs. number control 15 4 4 1,926 801 16 4 2 2,036 891 17 4 0 2,132 2,510 18 2 2 2 2,000 841 19 2 0 1,879 2,330 20 0 0 2,018 2,368
  • Various cocatalyst compounds which included lead(II) oxide, titanium(IV) oxide bis(2,4-pentanedionate), zinc 2,4-pentanedionate, copper(II) 2,4-pentanedionate, cerium(III) 2,4-pentanedionate, iron(III) 2,4-pentanedionate, manganese(III) 2,4-pentanedionate, europium(III) 2,4-pentanedionate and bismuth(III) 2,2,6,6-tetramethyl-3,5-heptanedionate, alone or in combination, were employed as component E.
  • the cosolvents employed were N-methylpyrrolidone (NMP), tetraethylene glycol dimethyl ether (“tetraglyme” TEG), polyethylene glycol dimethyl ether (PEG), sulfolane (SULF) and adiponitrile (ACN).
  • NMP N-methylpyrrolidone
  • TEG tetraethylene glycol dimethyl ether
  • PEG polyethylene glycol dimethyl ether
  • SULF sulfolane
  • ACN adiponitrile

Abstract

Hydroxyaromatic compounds such as phenol are carbonylated with oxygen and carbon monoxide in the presence of a catalyst system comprising a Group VIIIB metal, preferably palladium; at least one bromide or chloride salt, preferably sodium bromide or a tetraalkylammonium bromide; at least one organic bisphosphine such as 1,3-bis(diphenylphosphino)propane or 1,4-bis(diphenylphosphino)butane; and a compound of a metal other than a Group VIII metal having an atomic number of at least 44, preferably a lead bromophenoxide. There may also be present a polar organic liquid as a cosolvent.

Description

    BACKGROUND OF THE INVENTION
  • This invention relates to the preparation of diaryl carbonates by carbonylation. More particularly, it relates to the improvement of diaryl carbonate yield in the carbonylation reaction. [0001]
  • Diaryl carbonates are valuable intermediates for the preparation of polycarbonates by transesterification with bisphenols in the melt. This method of polycarbonate preparation has environmental advantages over methods that employ phosgene, a toxic gas, as a reagent and environmentally detrimental chlorinated aliphatic hydrocarbons such as methylene chloride as solvents. [0002]
  • Various methods for the preparation of diaryl carbonates by an oxidative carbonylation (hereinafter sometimes simply “carbonylation” for brevity) reaction of hydroxyaromatic compounds with carbon monoxide and oxygen have been disclosed. In general, the carbonylation reaction requires a rather complex catalyst. Reference is made, for example, to U.S. Pat. No. 4,187,242, in which the catalyst is a heavy Group VIII metal; i.e., a Group VIII metal having an atomic number of at least 44, said metals consisting of ruthenium, rhodium, palladium, osmium, iridium and platinum, or a complex thereof. Palladium catalysts have been found particularly useful; they include complexes with phosphines such as triphenylphosphine. [0003]
  • The production of carbonates may frequently be improved by including a metal-based cocatalyst along with the heavy Group VIII metal catalyst. Metal-based cocatalysts have been described broadly in U.S. Pat. Nos. 4,187,242, 4,201,721 and 5,380,907. Lead compounds as cocatalysts are particularly detailed in U.S. Pat. No. 5,498,789. Also preferred in general is the use of various halides, as illustrated by tetra-n-butylammonium bromide. Compounds characterized as inert solvents, such as toluene, diethyl ether, diphenyl ether and acetonitrile, can also be present. [0004]
  • Many of the catalyst systems known in the art have disadvantages such as low active catalyst lifetime, typically 2 hours or less, and low selectivity to the desired diaryl carbonate as a result of formation of relatively high proportions of by-products such as bromophenols. [0005]
  • Also, it has been observed that certain palladium-based catalysts, such as palladium(II) acetate, show a decrease in catalytic activity upon storage in contact with hydroxyaromatic compounds such as phenol at temperatures on the order of 70° C. for periods as short as 2 hours. This decrease is notable particularly when the palladium compound is present in catalyst mixtures containing lead(II) oxide. [0006]
  • It is of interest, therefore, to develop catalyst systems that have long lifetimes, not decreased by storage, and which improve selectivity. [0007]
  • SUMMARY OF THE INVENTION
  • The present invention is based on the discovery that the presence of bisphosphines in carbonylation catalyst systems, whether added separately or as a preformed complex with the Group VIII metal, affords a catalyst with good activity and relatively long storage stability. [0008]
  • In one of its aspects, therefore, the invention is directed to a method for preparing a diaryl carbonate. An embodiment of the method comprises contacting at least one hydroxyaromatic compound with oxygen and carbon monoxide in the presence of a catalytic amount of a catalyst composition comprising at least one organic bisphosphine and the following optional components and any reaction products thereof: a Group VIII metal having an atomic number of at least 44 or a compound thereof; at least one bromide or chloride salt; and at least one cocatalyst which is a compound of a metal other than a Group VIII metal having an atomic number of at least 44. [0009]
  • Another aspect of the invention is catalyst compositions comprising the aforementioned components and any reaction products thereof. [0010]
  • DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
  • Any hydroxyaromatic compound may be employed in the method of the present invention. Monohydroxyaromatic compounds, such as phenol, the cresols, the xylenols and p-cumylphenol, are generally preferred with phenol being most preferred. The invention may, however, also be employed with dihydroxyaromatic compounds such as resorcinol, hydroquinone and 2,2-bis(4-hydroxyphenyl)propane or “bisphenol A”, whereupon the products are polycarbonate oligomers. [0011]
  • Other reagents in the diaryl carbonate preparation method of the invention are oxygen and carbon monoxide, which react with the phenol to form the desired diaryl carbonate. They may be employed in high purity form or diluted with another gas such as nitrogen, argon or carbon dioxide, which has no negative effect on the reaction. [0012]
  • For the sake of brevity, the constituents of the catalyst system of the invention are defined as “components” irrespective of whether a reaction between said constituents occurs before or during the carbonylation reaction. Thus, the catalyst system may include said components and any reaction products thereof. [0013]
  • Component A of the catalyst system is one of the heavy Group VIII metals, preferably palladium, or a compound thereof. Thus, useful palladium materials include elemental palladium-containing entities such as palladium black, palladium/carbon, palladium/alumina and palladium/silica; palladium compounds such as palladium chloride, palladium bromide, palladium iodide, palladium sulfate, palladium nitrate, palladium acetate and palladium 2,4-pentanedionate; and palladium-containing complexes involving such compounds as carbon monoxide, amines, nitrites, phosphines and olefins. Preferred in many instances are palladium(II) salts of organic acids, most often C[0014] 2-6 aliphatic carboxylic acids, and palladium(II) salts of β-diketones. Palladium(II) acetate and palladium(II) 2,4-pentanedionate are generally most preferred. Mixtures of the aforementioned palladium materials are also contemplated.
  • Component B is at least one bromide or chloride salt. It may be an alkali metal or alkaline earth metal halide, preferably a bromide such as lithium bromide, sodium bromide, potassium bromide, calcium bromide or magnesium bromide. It may also be a quaternary ammonium or quaternary phosphonium salt such as tetramethylammonium bromide, tetraethylammonium bromide, tetra-n-butylammonium bromide or tetramethylphosphonium bromide, or a hexaalkylguanidinium salt such as hexaethylguanidinium bromide. [0015]
  • Component C is at least one organic bisphosphine. By “organic” is meant a compound containing at least one organic radical, with the proviso that said compound may also contain non-organic atoms or radicals. Thus, the bisphosphine may often be characterized by the formula [0016]
  • (R1)2P-R2-P(R1)2,  (I)
  • wherein each R[0017] 1 is independently a monovalent organic radical and R2 is a divalent organic radical. Most often, R1 is an aromatic or alicyclic radical, preferably aromatic and most preferably phenyl.
  • The identity of the divalent R[0018] 2 radical is subject to wide variation. It may be aliphatic, as exemplified by ethylene, trimethylene, tetramethylene and neopentylene. It may also be aromatic, as illustrated by phenylene and naphthylene. Suitable radicals include those containing inorganic elements, as illustrated by aminobis(alkylene) and ferrocenylene. For the most part, aliphatic radicals are preferred and C3-8 aliphatic radicals especially preferred.
  • Many bisphosphines of formula I, particularly the ones in which R[0019] 2 is aliphatic, are commercially available; examples are 1,3-bis(diphenylphosphino)propane and 1,4-bis(diphenylphosphino)butane. Other bisphosphines can be prepared by art-recognized methods.
  • Bisphosphines are included in the carbonylation catalyst system in catalytic amounts. In this context a “catalytic amount” is an amount of bisphosphine (or combination of bisphosphines) that increases the number of moles of diaryl carbonate produced per mole of Group VIII metal utilized; increases the number of moles of diaryl carbonate produced per mole of halide utilized; or increases selectivity toward diaryl carbonate production beyond that obtained in the absence of the bisphosphine (or combination of bisphosphines). Optimum amounts of a bisphosphine in a given application will depend on various factors, such as the identity of reactants and reaction conditions. [0020]
  • It is within the scope of the invention to introduce component C, the bisphosphine, into the catalyst mixture as a discrete compound. It is also contemplated to preform a complex of the bisphosphine with the Group VIII metal of component A, whereupon components A and C are introduced as a single entity. This may be achieved, for example, by a ligand interchange reaction between the bisphosphine and a palladium(II) halide complex with another ligand such as acetonitrile. [0021]
  • The preparation of a palladium(II) bisphosphine complex is illustrated by the following example. [0022]
  • EXAMPLE 1
  • A 100-ml round-bottomed flask was charged with 484.0 mg (1.87 mmol) of commercial grade palladium(II) chloride-acetonitrile complex and 30 ml of acetonitrile. The resulting solution was heated to about 40° C. with vigorous stirring until the palladium salt completely dissolved; a bright orange homogeneous solution resulted. To the stirred solution was added, in one portion, 797.0 mg (1.87 mmol) of 1,4-bis(diphenylphosphino)butane. The phosphine readily dissolved, and a pale yellow precipitate formed instantly. The suspension thus formed was stirred for an additional 5 minutes at room temperature and then cooled in an ice bath for 30 minutes to complete precipitation. The pale yellow precipitate was filtered in air on a medium pore fritted glass filter and washed with reagent grade hexane. It was then dried under vacuum. The yield of the desired palladium(II) chloride bisphosphine complex, whose structure was confirmed by phosphorus-31 nuclear magnetic resonance spectroscopy, was 1.062 g, or 94% of theoretical. [0023]
  • Also present in the catalyst composition is (D) at least one cocatalyst which is a compound of a metal other than a heavy Group VIII metal, preferably one which is soluble in the liquid phase under the reaction conditions. Numerous other metal compounds are known in the art to be active as carbonylation cocatalysts, and any compound having such activity may be used according to the present invention provided an improvement in diphenyl carbonate production, usually yield, is achieved thereby. [0024]
  • Illustrative cocatalytic metals include cerium, titanium, copper, zinc, manganese, bismuth, europium and lead, which may be used singly or in combination. It should be noted, however, that not all possible permutations of component D are operative in all contexts; the effectiveness of any metal compound or combination of compounds for this purpose may be determined by simple experimentation. The preferred cocatalytic compounds are those of lead. [0025]
  • Examples of lead compounds which may be employed are lead oxides such as PbO and Pb[0026] 3O4; inorganic lead salts such as lead(II) nitrate; lead carboxylates such as lead(II) acetate, lead(II)propionate and lead(IV) acetate; lead alkoxides and aryloxides such as lead(II) methoxide and lead(II) phenoxide; and lead salts of β-diketones such as lead(II) 2,4-pentanedionate. Mixtures of the aforementioned lead compounds may also be employed. The preferred lead compounds are lead(II) oxide, lead(II) aryloxides and lead(II) 2,4-pentanedionate. The preferred compounds of other metals are, for the most part, salts of P-diketones and especially 2,4-pentanedionates.
  • A subgenus of lead cocatalytic compounds that are particularly useful according to the invention is the subgenus of lead halophenoxides, typically having the formula [0027]
  • PbnOm(OA)(2-z)(n-m)Xz(n-m),  (II)
  • wherein A is an aromatic radical, X is chlorine or bromine, n has a value in the range of 1-3, m has a value in the range of 0-1 and z has a value in the range of 0.1-2.0. [0028]
  • In formula II, A may be any aromatic radical, unsubstituted or substituted. In general, A corresponds to the diaryl carbonate to be formed in the carbonylation reaction. Therefore, it is usually unsubstituted phenyl. X may be bromide or chloride and is preferably bromide. [0029]
  • The values of n, m and z are as described hereinabove. Most often, n is 2.5-3 and m is 0.8-1. [0030]
  • The lead halophenoxides may be prepared by merely bringing into contact, usually at a temperature in the range of about 50-120° C., lead(II) oxide, at least one bromide or chloride salt and at least one hydroxyaromatic compound, most often phenol. Suitable bromide and chloride salts include alkali metal and alkaline earth metal bromides and chlorides and tetraalkylammonium, tetraalkylphosphonium and hexaalkylguanidinium bromides and chlorides. The bromides are strongly preferred. When the bromide or chloride salt is an inorganic salt such as sodium bromide, the reaction is preferably facilitated by the presence of an electron-donating compound, especially a nitrile such as acetonitrile. [0031]
  • The molar ratio of lead to halide in the reaction mixture should be at least 2:1, since at lower molar ratios the principal products are the lead(II) halides and hydroxyhalides. In general, molar ratios in the range of about 2-20:1 are preferred. It should be noted, however, that the molar ratio of lead to halide in the product is not necessarily at least 2:1. Rather, the method of the invention involves this minimum since it permits isolation of the lead halophenoxide. [0032]
  • Hydroxyaromatic compound is most often present in excess and is preferably employed as a solvent for the reaction. The electron-donating compound, when employed, may also be present in molar excess with respect to halide salt, typically in a molar ratio in the range of about 50-200:1. Under such conditions, the lead halophenoxide forms a separate phase, which may be isolated by conventional methods including such operations as filtration and drying. [0033]
  • The preparation of lead halophenoxides is illustrated by the following, non-limiting Examples. [0034]
  • EXAMPLES 2-7
  • Various proportions of tetra-n-butylammonium bromide (TBAB) or hexaethylguanidinium bromide (HEGB) and phenol (PhOH) were combined with lead(II) oxide (PbO) and the resulting mixtures were stirred overnight at 70° C. After cooling to room temperature, the solid precipitates were removed by filtration, washed twice with acetonitrile and dried in a vacuum oven at 100° C. [0035]
  • EXAMPLES 8-9
  • Lead(II) oxide (PbO), 2.715 g, was dissolved in 10 ml of phenol (PhOH) at 100° C. and the resulting solution was added to various amounts of sodium bromide suspended in a mixture of 5 ml of phenol and 5 ml of acetonitrile (ACN). The resulting mixtures were stirred overnight at 100° C. After cooling to room temperature, the solid precipitates, which were the desired lead bromophenoxides, were removed by filtration, washed twice with acetonitrile and dried in a vacuum oven at 100° C. [0036]
  • The proportions and analyses applicable to the products of Examples 2-9 are given in Table I. [0037]
    TABLE I
    Example 2 3 4 5 6 7 8 9
    Bromide:
    Identity TBAB TBAB HEGB HEGB HEGB HEGB NaBr NaBr
    Amount, mg 570 2,850 540 510 570 155 150 75
    PbO, mg 1,000 5,030 1,000 1,800 2,500 1,800 2,700 2,700
    Molar ratio, Pb/Br 2.5 2.55 2.55 4.4 6.8 16.0 8.3 16.6
    Solvent:
    Identity PhOH PhOH PhOH PhOH PhOH PhOH PhOH/ PhOH/
    ACN ACN
    Amount, ml 10 50 10 10 10 10 20 20
    Yield, %* 62.0 44.0 65.7 68.0 49.7 38.8 36.1 87.8
    Br, % 8.0 8.8 8.3 5.2 5.4 2.1 6.3 1.4
    Pb, % 62.9 61.8 63.5 62.0 60.9 58.7 60.3 58.6
  • The presence of (E) a cosolvent in the catalyst system is also often preferred. Suitable cosolvents include various polar organic liquids such as ethers including polyethylene glycol ethers, amides such as N-methylpyrrolidone, sulfones such as sulfolane and nitrites such as acetonitrile and adiponitrile. It should be noted, however, that component E is not effective to optimize diaryl carbonate formation for all possible permutations of component D; the combined effectiveness of the two for this purpose may be determined by simple experimentation. [0038]
  • In addition to the aforementioned reactants and catalyst system, it is strongly preferred for a desiccant to be present in the reaction system. The preferred desiccants are non-reactive materials such as molecular sieves, as illustrated by 3-Angstrom (hereinafter “3A”) molecular sieves. They are usually isolated from the other reactants, as by presence in a basket mounted to a stirrer shaft or the like. [0039]
  • Component A is most often present in the amount of about 0.1-10,000 ppm by weight of the appropriate Group VIII metal (usually palladium), based on hydroxyaromatic compound, and component B in the amount of about 1-2,000 equivalents of halide per equivalent of the Group VIII metal of component A. Component C is present in an amount effective to form a complex with the metal of component A; this amount is generally at least a number of moles equal to the number of gram-atoms of metal in said component A, and preferably in a ratio of moles of component C to gram-atoms of said metal in the range of about 1.0-1.2:1. Component D, when present, is generally employed in the amount of about 0.2-200 gram-atoms of total metal per equivalent of the Group VIII metal of component A. [0040]
  • The role of component E in the composition and method of the invention is believed to be to increase the degree of dissociation and ionization of the halide anion of component B, perhaps by forming a complex with the cationic portion of said component, although the invention is in no way dependent on this or any other theory of operation. The amount of component E employed will be an amount effective to increase the yield of the desired diaryl carbonate as evidenced, for example, by an increase in “turnover number”; i.e., the number of moles of diaryl carbonate formed per gram-atom of palladium present. This amount is most often about 1-60% by volume based on the total of hydroxyaromatic compound and component E. [0041]
  • The method of the invention is preferably conducted in a reactor in which the hydroxyaromatic compound and catalyst system are charged under pressure of carbon monoxide and oxygen and heated. The reaction pressure is most often within the range of about 1-500 and preferably about 1-150 atm. Gas is usually supplied in proportions of about 1-50 mole percent oxygen with the balance being carbon monoxide and optionally one or more inert gases, and in any event outside the explosion range for safety reasons. The gases may be introduced separately or as a mixture. Reaction temperatures in the range of about 60-150° C. are typical. It is often preferred to maintain a substantially constant gas pressure and partial pressure of carbon monoxide and oxygen, as described, for example, in U.S. Pat. No. 5,399,734, until conversion of the hydroxyaromatic compound is complete. [0042]
  • The diaryl carbonates produced by the method of the invention may be isolated by conventional techniques. It is often preferred to form and thermally crack an adduct of the diaryl carbonate with the hydroxyaromatic compound, as described in U.S. Pat. Nos. 5,239,106 and 5,312,955. [0043]
  • The method of the invention is illustrated by the following examples. Minor variations in reagent amounts from one example to another are not believed significant from the standpoint of yield. [0044]
  • EXAMPLES 10-14
  • In each experiment, a high pressure reactor equipped with a stirrer was charged with approximately 61.318 g (651 mmol) of phenol, 301 mg of the lead bromophenoxide of Example 3, 1,750 mg (8.32 mmol) of tetraethylammonium bromide and a preformed mixture of 4.8 mg (0.016 mmol) of palladium(II) 2,4-pentanedionate and 0.016 mmol of one of the following bisphosphines: [0045]
  • DPPP- 1,3-bis(diphenylphosphino)propane, [0046]
  • DPPB-1,4-bis(diphenylphosphino)butane, [0047]
  • DPPF-bis(diphenylphosphino)ferrocene, [0048]
  • DCPF-bis(dicyclohexylphosphino)ferrocene, [0049]
  • DPAP-bis(diphenylphosphino)propylamine. [0050]
  • Freshly activated Type 3A molecular sieves, 38 g, were placed in a perforated polytetrafluoroethylene basket mounted on the stirrer shaft. [0051]
  • The reactor was sealed, flushed twice with carbon monoxide, pressurized with 88.4 atmospheres of a carbon monoxide-oxygen mixture containing 7.5% oxygen by volume and heated for 5 hours at 100° C., with vigorous stirring and periodic sampling via a sample dip tube. [0052]
  • When the reaction was complete, the reactor contents were cooled and analyzed. The results are given in Table II, as averages of quadruplicate runs. “Turnover number” is the number of moles of diaryl carbonate formed per gram-atom of palladium present, and “selectivity” (to diphenyl carbonate) is the amount of diphenyl carbonate produced as a percentage of total reaction products derived from phenol. Comparison is made with a control in which no bisphosphine was employed. [0053]
    TABLE II
    Turnover Selectivity,
    Example Bisphosphine number %
    10 DPPP 6,075 77.0
    11 DPPB 5,260 82.3
    12 DPPF 4,490 61.4
    13 DCPF 4,690 56.0
    14 DPAP 6,040 65.8
    Control 4,340 67.2
  • As demonstrated in Table II, the turnover numbers in the examples are higher than that of the control. In particular, excellent turnover numbers are produced by the bisphosphines in which R[0054] 2 is aliphatic. Certain compositions of the invention (Examples 10 and 11) also afford higher selectivities than the control.
  • EXAMPLES 15-20
  • Carbonylation experiments were conducted in small vials, employing a catalyst system containing 12 equivalents of lead(II) oxide, 5.6 equivalents of cerium(III) 2,4-pentanedionate and 400 equivalents of tetraethylammonium bromide per equivalent of palladium. The palladium catalysts were stored for various periods before use, and the reaction mixtures in various examples were stored at 70° C. for various periods. The proportion of palladium was 0.25 mmol per mmol of phenol and the reaction volume was 25 μl. [0055]
  • Each vial was capped with a snap cap having a slit with a polytetrafluoroethylene septum and the vials were placed in an autoclave which was pressurized to 88.4 atm with a mixture of 90 mole percent carbon monoxide and 10 mole percent oxygen and heated at 100° C. for 3 hours. The contents of the vials were analyzed for diphenyl carbonate by vapor phase chromatography. The results are given in Table III, in comparison with controls employing palladium(II) 2,4-pentanedionate as a catalyst. [0056]
    TABLE III
    Heated Turnover
    Catalyst mixture Turnover number,
    Example storage, hrs. storage, hrs. number control
    15 4 4 1,926 801
    16 4 2 2,036 891
    17 4 0 2,132 2,510
    18 2 2 2,000 841
    19 2 0 1,879 2,330
    20 0 0 2,018 2,368
  • It can be seen that the palladium(II) 2,4-pentanedionate catalyst systems show a very significant decrease in turnover number upon storage of the reaction mixture, although storage of the catalyst itself has no significant effect (compare Examples 17, 19 and 20). By contrast, the turnover numbers resulting from use of the catalyst systems of the present invention remain comparable under the same conditions. [0057]
  • The same pattern was not observed in catalyst systems not containing lead and cerium but containing copper(II) 2,4-pentanedionate, a homogeneous catalyst constituent. Turnover numbers of the same order of magnitude were observed irrespective of catalyst storage and reaction mixture storage for periods up to 20 and 4 hours, respectively. [0058]
  • EXAMPLES 21-53
  • Carbonylation experiments were conducted in small vials as described in Examples 15-20, employing the palladium(II) chloride bisphosphine complex of Example 1; sodium bromide (NaBr), calcium bromide (CaBr[0059] 2) or tri-n-butylammonium bromide (TBAB); and various cosolvents at levels of 24 ppm of palladium based on phenol, 240 equivalents of bromide per equivalent of palladium and 35% cosolvent by volume based on phenol-cosolvent mixture. Various cocatalyst compounds which included lead(II) oxide, titanium(IV) oxide bis(2,4-pentanedionate), zinc 2,4-pentanedionate, copper(II) 2,4-pentanedionate, cerium(III) 2,4-pentanedionate, iron(III) 2,4-pentanedionate, manganese(III) 2,4-pentanedionate, europium(III) 2,4-pentanedionate and bismuth(III) 2,2,6,6-tetramethyl-3,5-heptanedionate, alone or in combination, were employed as component E. The cosolvents employed were N-methylpyrrolidone (NMP), tetraethylene glycol dimethyl ether (“tetraglyme” TEG), polyethylene glycol dimethyl ether (PEG), sulfolane (SULF) and adiponitrile (ACN).The gas mixture consisted of 91.7 mole percent carbon monoxide and 8.3 mole percent oxygen.
  • The results are given in Table IV, as averages for triplicate runs. Cocatalyst proportions are in equivalents per equivalent of palladium. Comparison is made with controls in which no cosolvent was used and the proportion of phenol was increased correspondingly. [0060]
    TABLE IV
    Turnover
    Ex- Turnover number,
    ample Cocatalyst (eq) Halide Cosolvent number control
    21 Cu(20) NaBr NMP 713 222
    22 Cu(20) NaBr TEG 1,023 222
    23 Cu(20) NaBr PEG 1,065 222
    24 Cu(20) NaBr SULF 588 222
    25 Ti(10), Zn(20) NaBr NMP 697 158
    26 Ti(10), Zn(20) NaBr TEG 483 158
    27 Ti(10), Zn(20) NaBr PEG 429 158
    28 Ti(10), Zn(20) NaBr SULF 735 158
    29 Ti(10), Zn(20) NaBr ACN 600 158
    30 Pb(24), Ce(10) NaBr NMP 1,342 665
    31 Pb(24), Ce(10) NaBr TEG 1,456 665
    32 Pb(24), Ce(10) NaBr PEG 1,318 665
    33 Pb(24), Ce(10) NaBr SULF 1,058 665
    34 Pb(24), Ce(10) NaBr ACN 1,111 665
    35 Pb(24), Ti(5.6) NaBr NMP 1,373 547
    36 Pb(24), Ti(5.6) NaBr TEG 1,321 547
    37 Pb(24), Ti(5.6) NaBr PEG 613 547
    38 Pb(24), Ti(5.6) NaBr SULF 962 547
    39 Pb(24), Ti(5.6) NaBr ACN 835 547
    40 Pb(24), Ce(10) CaBr2 TEG 485 183
    41 Cu(10), Fe(10) NaBr PEG 88  40
    42 Cu(10), Mn(10) NaBr NMP 161 100
    43 Cu(10), Mn(10) NaBr TEG 420 100
    44 Cu(10), Mn(10) NaBr PEG 377 100
    45 Cu(10), Mn(10) NaBr SULF 233 100
    46 Bi(20), Eu(20) NaBr NMP 270 146
    47 Bi(20), Eu(20) NaBr TEG 333 146
    48 Bi(20), Eu(20) NaBr PEG 304 146
    49 Bi(20), Eu(20) NaBr SULF 289 146
    50 Bi(20), Eu(20) NaBr ACN 365 146
    51 Ce(10), Zn(50) TBAB NMP 253 179
    52 Ce(10), Zn(50) TBAB TEG 259 179
    53 Ce(10), Zn(50) TBAB PEG 222 179
  • Based on the above results, the benefit of using cosolvents in these particular catalyst combinations is apparent. [0061]
  • It will be understood that each of the elements described above, or two or more together, may also find utility in applications differing from the types described herein. While the invention has been illustrated and described as embodied in a catalyst composition and method for producing diaryl carbonates using bisphosphines, it is not intended to be limited to the details shown, since various modifications and substitutions can be made without departing in any way from the spirit of the present invention. For example, additional effective IOCC compounds can be added to the reaction. As such, further modifications and equivalents of the invention herein disclosed may occur to persons skilled in the art using no more than routine experimentation, and all such modifications and equivalents are believed to be within the spirit and scope of the invention as defined by the following claims. [0062]

Claims (43)

What is claimed is:
1. A method for preparing a diaryl carbonate, said method comprising the step of contacting at least one hydroxyaromatic compound with oxygen and carbon monoxide in the presence of a carbonylation catalyst system comprising a catalytic amount of at least one organic bisphosphine.
2. The method of
claim 1
, wherein the carbonylation catalyst system further comprises catalytic amounts of the following components and any reaction products thereof:
(A) a Group VIII metal having an atomic number of at least 44 or a compound thereof,
(B) at least one bromide or chloride salt, and (C) at least one cocatalyst that is a compound of a metal other than a Group VIII metal having an atomic number of at least 44.
3. The method of
claim 2
, wherein component B is at least one bromide salt.
4. The method of
claim 1
, wherein the organic bisphosphine has the formula
(R1)2P-R2-P(R1)2,  (I)
wherein each R1 is independently a monovalent organic radical and R2 is a divalent organic radical.
5. The method of
claim 4
, wherein each R1 is an aromatic or alicyclic radical.
6. The method of
claim 5
, wherein each R1 is phenyl.
7. The method of
claim 4
, wherein R2 is a C3-8 aliphatic radical.
8. The method of
claim 4
, wherein the organic bisphosphine is 1,3-bis(diphenylphosphino)propane.
9. The method of
claim 4
, wherein the organic bisphosphine is 1,4-bis(diphenylphosphino)butane.
10. The method of
claim 1
, wherein the organic bisphosphine is introduced into the catalytic material as a discrete compound.
11. The method of
claim 2
, wherein the organic bisphosphine is introduced into the catalytic material as a preformed complex with component A.
12. The method of
claim 2
, wherein the hydroxyaromatic compound is phenol.
13. The method of
claim 2
, wherein the Group VIIIB metal in component A is palladium.
14. The method of
claim 13
, wherein component A is palladium(II) acetate or palladium(II) 2,4-pentanedionate.
15. The method of
claim 2
, wherein component C comprises lead(II) oxide, a lead(II) aryloxide or lead(II) 2,4-pentanedionate.
16. The method of
claim 2
, wherein component C comprises a salt of at least one of cerium, titanium, copper, zinc, manganese, bismuth and europium.
17. The method of
claim 2
, wherein compound C comprises a lead bromophenoxide.
18. The method of
claim 2
, wherein component B is an alkali metal bromide.
19. The method of
claim 18
, wherein component B is sodium bromide.
20. The method of
claim 2
, wherein component B is a tetraalkylammonium bromide.
21. The method of
claim 2
, wherein there is also present (D) a cosolvent which is a polar organic liquid.
22. The method of
claim 21
, wherein component D is an ether, amide, sulfone or nitrile.
23. The method of
claim 2
, wherein a desiccant is also present.
24. The method of
claim 21
, wherein component A is present in the amount of about 0.1-10,000 ppm by weight of said Group VIII metal based on the total of hydroxyaromatic compound and the organic bisphosphine; component B in the amount of about 1-2,000 mmol per equivalent of the Group VIII metal of component A; the organic bisphosphine in a ratio of moles to gram-atoms of the Group VIII metal of component A in the range of about 1.0-1.2:1; component C in the amount of about 0.2-200 gram-atoms of total metal per equivalent of the Group VIII metal of component A; and component D, when present in the amount of 1-60% by volume based on the total of hydroxyaromatic compound and component D.
25. The method of
claim 2
, wherein the proportion of oxygen is about 1-50 mole percent based on total oxygen and carbon monoxide.
26. The method of
claim 2
, wherein a pressure in the range of about 1-500 atm and a temperature in the range of about 60-150° C. are maintained.
27. A method for preparing diphenyl carbonate which comprises contacting phenol with oxygen and carbon monoxide in the presence of an amount effective for carbonylation of at least one catalytic material comprising the following and any reaction products thereof:
(A) palladium or a compound thereof,
(B) at least one of sodium bromide and a tetraalkylammonium bromide,
(C) at least one of 1,3-bis(diphenylphosphino)propane and 1,4-bis(diphenylphosphino)butane and
(D) at least one lead bromophenoxide.
28. A catalyst composition comprising the following and any reaction products thereof:
(A) a Group VIII metal having an atomic number of at least 44 or a compound thereof,
(B) at least one bromide or chloride salt,
(C) at least one organic bisphosphine, and
(D) at least one cocatalyst that is a compound of a metal other than a Group VIII metal having an atomic number of at least 44.
29. The composition of
claim 28
, wherein component B is at least one bromide salt.
30. The composition of
claim 29
, wherein component C has the formula
(R1)2P-R2-P(R1)2,  (I)
wherein each R1 is independently a monovalent organic radical and R2 is a divalent organic radical.
31. The composition of
claim 30
, wherein each R1 is an aromatic or alicyclic radical.
32. The composition of
claim 31
, wherein each R1 is phenyl.
33. The composition of
claim 32
, wherein R2 is a C3-8 aliphatic radical.
34. The composition of
claim 28
, wherein the Group VIIIB metal in component A is palladium.
35. The composition of
claim 34
, wherein component A is palladium(II) acetate or palladium(II) 2,4-pentanedionate.
36. The composition of
claim 28
, wherein component D comprises lead(II) oxide, a lead(II) aryloxide or lead(II) 2,4-pentanedionate.
37. The composition of
claim 28
, wherein component D comprises a salt of at least one of cerium, titanium, copper, zinc, manganese, bismuth and europium.
38. The composition of
claim 28
, wherein compound D comprises a lead bromophenoxide.
39. The composition of
claim 28
, wherein component B is sodium bromide.
40. The composition of
claim 39
, wherein component B is a tetraalkylammonium bromide.
41. The composition of
claim 28
, further comprising (E) a cosolvent which is a polar organic liquid.
42. The composition of
claim 41
, wherein component E is an ether, amide, sulfone or nitrile.
43. A catalyst composition comprising the following and any reaction products thereof:
(A) palladium or a compound thereof,
(B) at least one of sodium bromide and a tetraalkylammonium bromide,
(C) at least one of 1,3-bis(diphenylphosphino)propane and 1,4-bis(diphenylphosphino)butane and
(D) at least one lead bromophenoxide.
US09/813,394 1999-12-20 2001-03-21 Catalyst composition and method for producing diaryl carbonates, using bisphosphines Expired - Fee Related US6407027B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US09/813,394 US6407027B2 (en) 1999-12-20 2001-03-21 Catalyst composition and method for producing diaryl carbonates, using bisphosphines

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/466,031 US6245929B1 (en) 1999-12-20 1999-12-20 Catalyst composition and method for producing diaryl carbonates, using bisphosphines
US09/813,394 US6407027B2 (en) 1999-12-20 2001-03-21 Catalyst composition and method for producing diaryl carbonates, using bisphosphines

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/466,031 Division US6245929B1 (en) 1999-12-20 1999-12-20 Catalyst composition and method for producing diaryl carbonates, using bisphosphines

Publications (2)

Publication Number Publication Date
US20010014753A1 true US20010014753A1 (en) 2001-08-16
US6407027B2 US6407027B2 (en) 2002-06-18

Family

ID=23850168

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/466,031 Expired - Fee Related US6245929B1 (en) 1999-12-20 1999-12-20 Catalyst composition and method for producing diaryl carbonates, using bisphosphines
US09/813,394 Expired - Fee Related US6407027B2 (en) 1999-12-20 2001-03-21 Catalyst composition and method for producing diaryl carbonates, using bisphosphines

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/466,031 Expired - Fee Related US6245929B1 (en) 1999-12-20 1999-12-20 Catalyst composition and method for producing diaryl carbonates, using bisphosphines

Country Status (7)

Country Link
US (2) US6245929B1 (en)
EP (1) EP1242358B1 (en)
JP (1) JP2003518083A (en)
AT (1) ATE267160T1 (en)
AU (1) AU1814601A (en)
DE (1) DE60010929T2 (en)
WO (1) WO2001046119A1 (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015034928A1 (en) 2013-09-03 2015-03-12 Moderna Therapeutics, Inc. Chimeric polynucleotides
US8980864B2 (en) 2013-03-15 2015-03-17 Moderna Therapeutics, Inc. Compositions and methods of altering cholesterol levels
US8999380B2 (en) 2012-04-02 2015-04-07 Moderna Therapeutics, Inc. Modified polynucleotides for the production of biologics and proteins associated with human disease
US9107886B2 (en) 2012-04-02 2015-08-18 Moderna Therapeutics, Inc. Modified polynucleotides encoding basic helix-loop-helix family member E41
US9181319B2 (en) 2010-08-06 2015-11-10 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
US9186372B2 (en) 2011-12-16 2015-11-17 Moderna Therapeutics, Inc. Split dose administration
US9283287B2 (en) 2012-04-02 2016-03-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of nuclear proteins
US9334328B2 (en) 2010-10-01 2016-05-10 Moderna Therapeutics, Inc. Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
US9428535B2 (en) 2011-10-03 2016-08-30 Moderna Therapeutics, Inc. Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
US9464124B2 (en) 2011-09-12 2016-10-11 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
US9533047B2 (en) 2011-03-31 2017-01-03 Modernatx, Inc. Delivery and formulation of engineered nucleic acids
US9572897B2 (en) 2012-04-02 2017-02-21 Modernatx, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
US9597380B2 (en) 2012-11-26 2017-03-21 Modernatx, Inc. Terminally modified RNA
US10323076B2 (en) 2013-10-03 2019-06-18 Modernatx, Inc. Polynucleotides encoding low density lipoprotein receptor
EP4159741A1 (en) 2014-07-16 2023-04-05 ModernaTX, Inc. Method for producing a chimeric polynucleotide encoding a polypeptide having a triazole-containing internucleotide linkage

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197991B1 (en) * 1999-04-29 2001-03-06 General Electric Company Method and catalyst system for producing
US6215015B1 (en) * 2000-04-17 2001-04-10 General Electric Company Catalyst composition and method for producing diaryl carbonates, using bisphosphines
US6462217B1 (en) * 2000-10-30 2002-10-08 General Electric Company Oxidative carbonylation of hydroxyaromatic compounds
US7335791B1 (en) 2006-11-28 2008-02-26 E.I. Du Pont De Nemours And Company Process for the synthesis of hydroxy aromatic acids
US7355070B1 (en) * 2006-11-28 2008-04-08 E. I. Du Pont De Nemours And Company Process for the synthesis of 2,5-dihydroxyterephthalic acid
US7345195B1 (en) 2006-11-28 2008-03-18 E.I. Du Pont De Nemours And Company Process for the synthesis of 2,5-dihydroxyterephthalic acid
US7358391B1 (en) * 2006-11-28 2008-04-15 E.I. Du Pont De Nemours And Company Process for the synthesis of hydroxy aromatic acids
US7345194B1 (en) 2006-11-28 2008-03-18 E.I. Du Pont De Nemours And Company Process for the synthesis of 2,5-dihydroxyterephthalic acid
US7351856B1 (en) 2006-11-28 2008-04-01 E.I. Du Pont De Nemours And Company Process for the synthesis of hydroxy aromatic acids
US7378547B1 (en) * 2006-11-28 2008-05-27 E.I. Du Pont De Nemours And Company Process for the synthesis of hydroxy aromatic acids
US7339076B1 (en) * 2006-11-28 2008-03-04 E.I. Du Pont De Nemours And Company Process for the synthesis of 2,5-dihydroxyterephthalic acid

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4201721A (en) 1976-10-12 1980-05-06 General Electric Company Catalytic aromatic carbonate process
US4187242A (en) 1976-10-12 1980-02-05 General Electric Company Catalytic aromatic carbonate process
US4629804A (en) * 1983-09-16 1986-12-16 Catalytica Associates Process for preparation of urethanes
JPH0641020A (en) 1992-06-01 1994-02-15 Mitsubishi Gas Chem Co Inc Production of aromatic carbonate
EP0614876B1 (en) * 1993-03-08 1997-04-09 Mitsubishi Chemical Corporation Method of producing aromatic carbonate
BE1007410A3 (en) * 1993-08-23 1995-06-06 Dsm Nv PROCESS FOR THE PREPARATION OF A acetal.
DE69408968T2 (en) 1994-01-12 1998-07-30 Mitsubishi Chem Corp Process for producing an aromatic carbonate
GB9419762D0 (en) * 1994-09-30 1994-11-16 Bp Chem Int Ltd Catalyst composition
DE19512618A1 (en) * 1995-04-05 1996-10-10 Bayer Ag Supported catalysts containing platinum metal and process for the preparation of diaryl carbonates
US5618983A (en) * 1995-08-25 1997-04-08 E. I. Du Pont De Nemours And Company Hydroformylation process
US5739352A (en) * 1995-10-19 1998-04-14 United Carbide Chemicals & Plastics Technology Corporation Process for preparing carboxylic acids
JP3719545B2 (en) 1996-04-05 2005-11-24 三菱化学株式会社 Method for producing aromatic carbonate
US5898079A (en) * 1997-02-13 1999-04-27 General Electric Company Method for preparing diaryl carbonates employing hexaalkylguanidinium halides
US6197991B1 (en) * 1999-04-29 2001-03-06 General Electric Company Method and catalyst system for producing
US6215015B1 (en) * 2000-04-17 2001-04-10 General Electric Company Catalyst composition and method for producing diaryl carbonates, using bisphosphines

Cited By (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9447164B2 (en) 2010-08-06 2016-09-20 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
US9181319B2 (en) 2010-08-06 2015-11-10 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
US9937233B2 (en) 2010-08-06 2018-04-10 Modernatx, Inc. Engineered nucleic acids and methods of use thereof
US9657295B2 (en) 2010-10-01 2017-05-23 Modernatx, Inc. Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
US9334328B2 (en) 2010-10-01 2016-05-10 Moderna Therapeutics, Inc. Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
US10064959B2 (en) 2010-10-01 2018-09-04 Modernatx, Inc. Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
US9701965B2 (en) 2010-10-01 2017-07-11 Modernatx, Inc. Engineered nucleic acids and methods of use thereof
US9950068B2 (en) 2011-03-31 2018-04-24 Modernatx, Inc. Delivery and formulation of engineered nucleic acids
US9533047B2 (en) 2011-03-31 2017-01-03 Modernatx, Inc. Delivery and formulation of engineered nucleic acids
US9464124B2 (en) 2011-09-12 2016-10-11 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
US10022425B2 (en) 2011-09-12 2018-07-17 Modernatx, Inc. Engineered nucleic acids and methods of use thereof
US10751386B2 (en) 2011-09-12 2020-08-25 Modernatx, Inc. Engineered nucleic acids and methods of use thereof
US9428535B2 (en) 2011-10-03 2016-08-30 Moderna Therapeutics, Inc. Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
US9271996B2 (en) 2011-12-16 2016-03-01 Moderna Therapeutics, Inc. Formulation and delivery of PLGA microspheres
US9186372B2 (en) 2011-12-16 2015-11-17 Moderna Therapeutics, Inc. Split dose administration
US9295689B2 (en) 2011-12-16 2016-03-29 Moderna Therapeutics, Inc. Formulation and delivery of PLGA microspheres
US9303079B2 (en) 2012-04-02 2016-04-05 Moderna Therapeutics, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
US9107886B2 (en) 2012-04-02 2015-08-18 Moderna Therapeutics, Inc. Modified polynucleotides encoding basic helix-loop-helix family member E41
US9254311B2 (en) 2012-04-02 2016-02-09 Moderna Therapeutics, Inc. Modified polynucleotides for the production of proteins
US9255129B2 (en) 2012-04-02 2016-02-09 Moderna Therapeutics, Inc. Modified polynucleotides encoding SIAH E3 ubiquitin protein ligase 1
US9221891B2 (en) 2012-04-02 2015-12-29 Moderna Therapeutics, Inc. In vivo production of proteins
US9283287B2 (en) 2012-04-02 2016-03-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of nuclear proteins
US9220755B2 (en) 2012-04-02 2015-12-29 Moderna Therapeutics, Inc. Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders
US9301993B2 (en) 2012-04-02 2016-04-05 Moderna Therapeutics, Inc. Modified polynucleotides encoding apoptosis inducing factor 1
US10501512B2 (en) 2012-04-02 2019-12-10 Modernatx, Inc. Modified polynucleotides
US9220792B2 (en) 2012-04-02 2015-12-29 Moderna Therapeutics, Inc. Modified polynucleotides encoding aquaporin-5
US9216205B2 (en) 2012-04-02 2015-12-22 Moderna Therapeutics, Inc. Modified polynucleotides encoding granulysin
US9192651B2 (en) 2012-04-02 2015-11-24 Moderna Therapeutics, Inc. Modified polynucleotides for the production of secreted proteins
US9149506B2 (en) 2012-04-02 2015-10-06 Moderna Therapeutics, Inc. Modified polynucleotides encoding septin-4
US9114113B2 (en) 2012-04-02 2015-08-25 Moderna Therapeutics, Inc. Modified polynucleotides encoding citeD4
US9572897B2 (en) 2012-04-02 2017-02-21 Modernatx, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
US9587003B2 (en) 2012-04-02 2017-03-07 Modernatx, Inc. Modified polynucleotides for the production of oncology-related proteins and peptides
US8999380B2 (en) 2012-04-02 2015-04-07 Moderna Therapeutics, Inc. Modified polynucleotides for the production of biologics and proteins associated with human disease
US9233141B2 (en) 2012-04-02 2016-01-12 Moderna Therapeutics, Inc. Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders
US9675668B2 (en) 2012-04-02 2017-06-13 Moderna Therapeutics, Inc. Modified polynucleotides encoding hepatitis A virus cellular receptor 2
US9095552B2 (en) 2012-04-02 2015-08-04 Moderna Therapeutics, Inc. Modified polynucleotides encoding copper metabolism (MURR1) domain containing 1
US9782462B2 (en) 2012-04-02 2017-10-10 Modernatx, Inc. Modified polynucleotides for the production of proteins associated with human disease
US9814760B2 (en) 2012-04-02 2017-11-14 Modernatx, Inc. Modified polynucleotides for the production of biologics and proteins associated with human disease
US9828416B2 (en) 2012-04-02 2017-11-28 Modernatx, Inc. Modified polynucleotides for the production of secreted proteins
US9827332B2 (en) 2012-04-02 2017-11-28 Modernatx, Inc. Modified polynucleotides for the production of proteins
US9878056B2 (en) 2012-04-02 2018-01-30 Modernatx, Inc. Modified polynucleotides for the production of cosmetic proteins and peptides
US9089604B2 (en) 2012-04-02 2015-07-28 Moderna Therapeutics, Inc. Modified polynucleotides for treating galactosylceramidase protein deficiency
US9061059B2 (en) 2012-04-02 2015-06-23 Moderna Therapeutics, Inc. Modified polynucleotides for treating protein deficiency
US9050297B2 (en) 2012-04-02 2015-06-09 Moderna Therapeutics, Inc. Modified polynucleotides encoding aryl hydrocarbon receptor nuclear translocator
US9597380B2 (en) 2012-11-26 2017-03-21 Modernatx, Inc. Terminally modified RNA
US8980864B2 (en) 2013-03-15 2015-03-17 Moderna Therapeutics, Inc. Compositions and methods of altering cholesterol levels
WO2015034928A1 (en) 2013-09-03 2015-03-12 Moderna Therapeutics, Inc. Chimeric polynucleotides
US10323076B2 (en) 2013-10-03 2019-06-18 Modernatx, Inc. Polynucleotides encoding low density lipoprotein receptor
EP4159741A1 (en) 2014-07-16 2023-04-05 ModernaTX, Inc. Method for producing a chimeric polynucleotide encoding a polypeptide having a triazole-containing internucleotide linkage

Also Published As

Publication number Publication date
US6407027B2 (en) 2002-06-18
WO2001046119A1 (en) 2001-06-28
DE60010929T2 (en) 2005-05-19
EP1242358A1 (en) 2002-09-25
ATE267160T1 (en) 2004-06-15
US6245929B1 (en) 2001-06-12
JP2003518083A (en) 2003-06-03
EP1242358B1 (en) 2004-05-19
DE60010929D1 (en) 2004-06-24
AU1814601A (en) 2001-07-03

Similar Documents

Publication Publication Date Title
US6407027B2 (en) Catalyst composition and method for producing diaryl carbonates, using bisphosphines
EP1194395B1 (en) Catalyst composition and method for producing diaryl carbonates using nitrile as promoter
EP1212288B1 (en) Production of diaryl carbonates using amides as promoters
EP1212287B1 (en) Catalyst composition and method for producing diaryl carbonates
US6215014B1 (en) Catalyst composition and method for producing diaryl carbonates
US6617279B2 (en) Catalyst composition and method for producing diaryl carbonates, using bisphosphines
US6191299B1 (en) Method for making aromatic carbonates
US20020183539A1 (en) Method and catalyst system for producing aromatic carbonates
US6310229B1 (en) Lead halophenoxides and carbonylation catalyst and method for preparing and employing them
US6753288B2 (en) Oxidative carbonylation of hydroxyaromatic compounds
EP1140774A1 (en) Process for the production of diaryl carbonates

Legal Events

Date Code Title Description
REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20060618